Clinical studies of component ("acellular") pertussis vaccines have been undertaken in recent years and several acellular vaccines have been used in Japan for 9 years. The Committee has reviewed these trials and related data and herein provides its assessment regarding the current status of the acellular vaccines and their possible use in the United States.

This content is only available via PDF.
You do not currently have access to this content.